InspireMD, Inc. (NYSE American: NSPR), the developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by carotid artery disease, today announced the pricing of an u

Thinking about buying stock in Zomedica Pharmaceuticals, InspireMD, General Electric, Norwegian ...

12:00am, Wednesday, 03'rd Jun 2020

InspireMD shares are trading lower after the company reported a common stock offering.

02:08pm, Thursday, 14'th May 2020

InspireMD S-1 Shows Registration For $11.5M Common Stock Offering

01:57pm, Thursday, 14'th May 2020

InspireMD shares are trading higher after the company reported better-than-expected Q1 EPS and sales results.

11:19am, Tuesday, 12'th May 2020

InspireMD Announces First Quarter 2020 Financial Results

11:00am, Tuesday, 12'th May 2020

First quarter revenue growth driven by continued strong uptake of the CGuard™ Embolic Prevention System (EPS) in the company’s major markets Management to host investor.

The Daily Biotech Pulse: NASH Disappointment For Genfit, Novavax Lands $384M CEPI Funding For Coronavirus Vaccine, GW Pharma Earnings

12:00am, Tuesday, 12'th May 2020

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) Acceleron Pharma Inc (NASDAQ...

Weekly Note, May 11, 2020: Market May Be Entering A Quarantine

12:59pm, Monday, 11'th May 2020

Bad (economic) news is good news. Commodities are a bellwether. Q1 earnings beating expectations. Fiscal stimulus affecting money supply. Business conditions su

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by